Basilea Pharmaceutica AG
BPMUF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $1 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $0 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 32.3% | 6.7% | -0.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 81.5% | 83% | 83.3% | 83.7% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 31.8% | 14.7% | 14.7% | 2.4% |
| Net Income | $0 | $0 | $0 | -$0 |
| % Margin | 37.2% | 6.6% | 8.2% | -4.6% |
| EPS Diluted | 5.83 | 0.86 | 1.02 | -0.58 |
| % Growth | 577.9% | -15.7% | 275.9% | – |
| Operating Cash Flow | $0 | $0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | -$0 |